HighTower Advisors, LLC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 37 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$2,000
-95.0%
10,465
-0.5%
0.00%
Q1 2021$40,0000.0%10,516
+2.4%
0.00%
Q3 2019$40,000
-2.4%
10,2660.0%0.00%
Q2 2019$41,000
-10.9%
10,266
-4.6%
0.00%
Q1 2019$46,000
+17.9%
10,7660.0%0.00%
Q4 2018$39,000
-4.9%
10,7660.0%0.00%
Q3 2018$41,000
-2.4%
10,7660.0%0.00%
Q2 2018$42,000
+20.0%
10,7660.0%0.00%
Q1 2018$35,000
-16.7%
10,7660.0%0.00%
Q4 2017$42,0000.0%10,766
+4.9%
0.00%
Q3 2017$42,000
-2.3%
10,2660.0%0.00%
Q2 2017$43,000
-6.5%
10,266
-4.6%
0.00%
Q1 2017$46,000
+70.4%
10,7660.0%0.00%
Q4 2016$27,000
+3.8%
10,7660.0%0.00%
Q3 2016$26,0000.0%10,7660.0%0.00%
Q2 2016$26,000
-10.3%
10,7660.0%0.00%
Q1 2016$29,000
-46.3%
10,766
-12.2%
0.00%
-100.0%
Q1 2015$54,000
+10.2%
12,266
+19.5%
0.00%0.0%
Q4 2014$49,00010,2660.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q4 2018
NameSharesValueWeighting ↓
ABNER HERRMAN & BROCK LLC 239,000$2,679,0000.48%
EAM Investors, LLC 81,854$918,0000.20%
CFO4Life Group, LLC 12,003$135,0000.05%
Phoenix Holdings Ltd. 104,782$1,112,0000.05%
WINTON GROUP Ltd 118,487$1,328,0000.03%
Merit Financial Group, LLC 28,731$322,0000.03%
HighPoint Advisor Group LLC 13,533$151,0000.03%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 23,000$258,0000.02%
ETF MANAGERS GROUP, LLC 52,216$579,0000.02%
IHT Wealth Management, LLC 13,000$146,0000.02%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders